Patents by Inventor Valérie Nicolas

Valérie Nicolas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230149504
    Abstract: The present invention concerns alisporivir for use in treatment of a human patient suffering of COVID-19 infections and for prevention of a human patient from suffering of COVID-19 infections.
    Type: Application
    Filed: April 6, 2021
    Publication date: May 18, 2023
    Inventors: Jean-Michel PAWLOTSKY, Abdelhakim AHMED-BELKACEM, Laurent SOFTIC, Valérie NICOLAS, George BADITA, Raf CRABBE
  • Patent number: 8501683
    Abstract: At least one embodiment of the present invention relates to new cycloundecadepsipeptide compounds and to the use of said compounds as a medicament, in particular as antiviral agents, more particularly for preventing or treating Hepatitis C infections or HCV induced disorders.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: August 6, 2013
    Assignee: Debio Recherche Pharmaceutique S.A.
    Inventors: Roland Wenger, Manfred Mutter, Patrick Garrouste, Robert Lysek, Olivier Turpin, Grégoire Vuagniaux, Valérie Nicolas, Laura Novaroli Zanolari, Rafael Crabbé
  • Publication number: 20110212057
    Abstract: At least one embodiment of the present invention relates to new cycloundecadepsipeptide compounds and to the use of said compounds as a medicament, in particular as antiviral agents, more particularly for preventing or treating Hepatitis C infections or HCV induced disorders.
    Type: Application
    Filed: November 6, 2009
    Publication date: September 1, 2011
    Applicant: Debio Recherche Pharmaceutique S.A.
    Inventors: Roland Wenger, Manfred Mutter, Patrick Garrouste, Robert Lysex, Olivier Turpin, Grégoire Vuagniaux, Valérie Nicolas, Laura Novaroli Zanolari, Rafael Crabbé